Robert Alonso
Directeur/Membre du Conseil chez MEDESIS PHARMA S.A.
Profil
Robert J.
Alonso is the founder of Ceptaris Therapeutics, Inc. (founded in 2002) and Mitochon Pharmaceuticals, Inc. (founded in 2014) where he held the titles of President & Chief Executive Officer and Chief Executive Officer, respectively.
He is currently a Member-Supervisory Board at Medesis Pharma SA since 2022.
Mr. Alonso's former positions include being a Principal at Merck & Co., Inc., Roche Pharmaceuticals, Inc., and Layton BioScience, Inc. Mr. Alonso received an MBA degree from Babson College.
Postes actifs de Robert Alonso
| Sociétés | Poste | Début |
|---|---|---|
| MEDESIS PHARMA S.A. | Directeur/Membre du Conseil | 27/10/2022 |
Mitochon Pharmaceuticals, Inc.
 Mitochon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mitochon Pharmaceuticals, Inc. operates as a biotech company. It focuses on developing drugs that target the mitochondria for a host of serious diseases. The firm provides products to resolve the over-nutritional phenotype metabolic disorders. The company was founded by Robert Alonso and John G. Geisler in 2014 and is headquartered in Blue Bell, PA. | Directeur Général | 01/01/2014 |
Anciens postes connus de Robert Alonso
| Sociétés | Poste | Fin |
|---|---|---|
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Fondateur | 10/05/2011 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| Layton BioScience, Inc. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Robert Alonso
| Babson College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MEDESIS PHARMA S.A. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Mitochon Pharmaceuticals, Inc.
Mitochon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mitochon Pharmaceuticals, Inc. operates as a biotech company. It focuses on developing drugs that target the mitochondria for a host of serious diseases. The firm provides products to resolve the over-nutritional phenotype metabolic disorders. The company was founded by Robert Alonso and John G. Geisler in 2014 and is headquartered in Blue Bell, PA. | Health Technology |
| Layton BioScience, Inc. |